The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...

As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

“[Friday’s] decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA approved Wegovy for cardiovascular disease risk reduction early in ...